101 related articles for article (PubMed ID: 28976281)
1. Reflection on the governance of clinical stem cell research and applications in China.
Chen H
Regen Med; 2017 Sep; 12(6):593-597. PubMed ID: 28976281
[No Abstract] [Full Text] [Related]
2. New regulation for clinical stem cell research in China: expected impact and challenges for implementation.
Rosemann A; Sleeboom-Faulkner M
Regen Med; 2016 Jan; 11(1):5-9. PubMed ID: 26680327
[No Abstract] [Full Text] [Related]
3. Lost in translation? Accountability and governance of clinical stem cell research in China.
Zhang JY
Regen Med; 2017 Sep; 12(6):647-656. PubMed ID: 28976821
[TBL] [Abstract][Full Text] [Related]
4. [Report of the Central Ethics Committee for Stem Cell Research (ZES) : eighth report after the enactment of the Stem Cell Act (StZG), Reporting Period: 1 December 2009 to 31 December 2010].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jun; 54(6):760-5. PubMed ID: 21626382
[No Abstract] [Full Text] [Related]
5. Bioethics in China: No wild east.
Sipp D; Pei D
Nature; 2016 Jun; 534(7608):465-7. PubMed ID: 27337327
[No Abstract] [Full Text] [Related]
6. [Report of the Central Ethics Committee for Stem Cell Research (ZES)].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Jul; 56(7):985-91. PubMed ID: 23807406
[No Abstract] [Full Text] [Related]
7. Comparing national home-keeping and the regulation of translational stem cell applications: An international perspective.
Sleeboom-Faulkner M; Chekar CK; Faulkner A; Heitmeyer C; Marouda M; Rosemann A; Chaisinthop N; Chang HC; Ely A; Kato M; Patra PK; Su Y; Sui S; Suzuki W; Zhang X
Soc Sci Med; 2016 Mar; 153():240-9. PubMed ID: 26921839
[TBL] [Abstract][Full Text] [Related]
8. [Report of the Central Ethics Committee for Stem Cell Research (ZES): Eleventh Report of entry into enforcement of the Stem Cell Act (StZG) for the period from 01.01.2013 to 31.12.2013].
Zentrale Ethik-Kommission für Stammzellforschung
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jul; 57(7):903-9. PubMed ID: 25089308
[No Abstract] [Full Text] [Related]
9. Peering from the shadows: stem cell research and the quest for regulation in Argentina.
Harmon SH
Stem Cell Rev Rep; 2012 Sep; 8(3):640-6. PubMed ID: 22076753
[No Abstract] [Full Text] [Related]
10. [Not Available].
Zentrale Ethik-Kommission für Stammzellforschung
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Sep; 58(9):1015-22. PubMed ID: 26178854
[No Abstract] [Full Text] [Related]
11. Fraudsters operate and officialdom turns a blind eye: a proposal for controlling stem cell therapy in China.
Jiang L; Dong BH
Med Health Care Philos; 2016 Sep; 19(3):403-10. PubMed ID: 26906907
[TBL] [Abstract][Full Text] [Related]
12. Italian government sets up a stem cell trial to assuage public demands.
Turone F
BMJ; 2013 May; 346():f3499. PubMed ID: 23723454
[No Abstract] [Full Text] [Related]
13. Legal and regulatory news from Europe.
Hitchcock J
Stem Cells Dev; 2014 Dec; 23 Suppl 1():44-6. PubMed ID: 25457961
[TBL] [Abstract][Full Text] [Related]
14. Better safe than sorry: ethics review in European Union-funded health research.
Draghia-Akli R; Hoeveler A; Löffler P; Namorado J
Stem Cells Dev; 2014 Dec; 23 Suppl 1():47-50. PubMed ID: 25457962
[TBL] [Abstract][Full Text] [Related]
15. Trends and Prospects of Stem Cell Research in China.
Cao JW; Zhang L; Li Y; Yang Q; Fu WH; Wang XC; Huang WL
Chin Med Sci J; 2016 Jun; 31(2):116-120. PubMed ID: 28031100
[TBL] [Abstract][Full Text] [Related]
16. Stem cell policy in the Obama age: UK and US perspectives.
Matthews KR; Rowland ML
Regen Med; 2011 Jan; 6(1):125-32. PubMed ID: 21175292
[TBL] [Abstract][Full Text] [Related]
17. Research on Human Embryos and Reproductive Materials: Revisiting Canadian Law and Policy.
Ogbogu U; Zarzeczny A; Baltz J; Bedford P; Du J; Hyun I; Jaafar Y; Jurisicova A; Kleiderman E; Koukio Y; Knoppers BM; Leader A; Master Z; Nguyen MT; Noohi F; Ravitsky V; Toews M
Healthc Policy; 2018 Feb; 13(3):10-19. PubMed ID: 29595433
[TBL] [Abstract][Full Text] [Related]
18. Strategies for stem cell patent applications in the light of recent court cases.
Eyre DE; Schlich GW
Pharm Pat Anal; 2015; 4(6):431-41. PubMed ID: 26580992
[TBL] [Abstract][Full Text] [Related]
19. The regulatory sciences for stem cell-based medicinal products.
Yuan BZ; Wang J
Front Med; 2014 Jun; 8(2):190-200. PubMed ID: 24733351
[TBL] [Abstract][Full Text] [Related]
20. Alliances, collaborations and consortia: the International Stem Cell Forum and its role in shaping global governance and policy.
Isasi R
Regen Med; 2012 Nov; 7(6 Suppl):84-8. PubMed ID: 23210817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
